Determinants of Non-Disclosure to Sexual Partner among Human immune virus Infected Adults on Anti-Retroviral Therapy Follow-Up Care at North Shewa Zone public Hospitals in Oromia Region, Ethiopia, 2020.

Abstract

BackgroundHIV positive status non-disclosure to sexual partner remains challenging for the prevention and control of Human Immune Virus infection as it results in poor antiretroviral treatment adherence, high risk of transmission and limits women’s ability in the prevention of mother to child transmission. ObjectiveThe study tried to identify determinants of non-disclosure to sexual partner/s among Human immune virus infected Adult on Anti-Retroviral Therapy Follow-Up Care at North Shewa zone public Hospitals in Oromia Region, Ethiopia, 2020. MethodsA hospital based unmake case control study was conducted from December 1 to February 30/2020 among 378 (94 cases and 284 controls) Human immune virus infected adults on Anti-Retroviral Therapy Follow-Up Care at North Shewa zone public Hospitals in Oromia Region, Ethiopia, 2020. Epi data version 3.1 for data entry and SPSS version 25 for analysis were used. To find factors significantly associated with non-disclosure to sexual partner/s, Bivariable and Multivariable logistic regression analysis were done. ResultOf a total of 378 sampled study respondents, 369 were interviewed (92 cases and 277 controls) giving response rate of 97.5%. Among the study participants 39.3% (36 cases and 109 controls) were in the age group of 31-40 years and more than half of the respondents, 53.4% (61 cases and 136 controls) were females. Regarding educational and marital status, 39.3% (100 controls and 45 cases) were unable to read and write and 69.6% (211 controls and 46 cases) were married. Variables that showed significant association with non-disclosure to sexual partner were male sex (AOR: 0.25, 95% CI: 0.13-0.47), ART duration <36 months (AOR:2.13, 95% CI: 1.14-4.01), Being on WHO clinical staging one (AOR: 3.00, 95% CI: 1.26-7.12), Having more than one lifetime sexual partner (AOR: 0.46, 95% CI: 0.22-0.95) and not seeing person/s publically disclosed HIV status (AOR: 3.12, 95% CI: 1.47-6.65). ConclusionsThis study endorsed that promoting public HIV disclosure and having one sexual partner helps disclosure to sexual partner/s. Deep and continuous HIV disclosure counseling service is needed for Female, for those being in WHO clinical staging one and ART duration <36 months.